Cutting edge equipment and resources enables everyone in the centre to make ground breaking discoveries and translate them into patient benefit.
Proteomics
What does this do? Find markers we can measure to help with diagnosis, prognosis and treatment.
What is available and how do I access it? -
Q Exactive hybrid high-resolution mass spectrometer
Contact: Nicolas Stewart (n.stewart@brighton.ac.uk)
-
Orbitrap Exploris 480 with FAIMS Pro-Duo high-resolution mass spectrometer
Contact: Ramon Gonzalez-Mendez (R.Gonzalez-Mendez@sussex.ac.uk)
Scientific Officer - Mass Spectrometry
Microscopy
What does this do? Visualise tiny tumour cells, immune cells, and how they interact.What is available and how do I access it? -
Laser Microdissection System
Leica LMD7
Contact:
Mark Yeoman (m.yeoman@brighton.ac.uk)
Director for the Centre of Lifelong Health -
Two confocal microscopes
Five wide-field fluorescence microscopes
One high throughput microscope
Five low-light microscopes.
Contact:
Dr Yan Gu (yg90@sussex.ac.uk)
Manager of The Wolfson Biological Imaging Centre
Flow Cytometry
What does this do? Provides crucial data on cancer cell types and response to treatment.
What is available and how do I access it? -
Beckman Coulter Cytoflex (3 laser, 7 channel)
BD Accuri C6 (2 lasers 4 channels)
BD FACSMelody Cell Sorter (3 lasers, 8 channels)
Contact: Jon Wing (J.F.Wing@sussex.ac.uk)
Technical Specialist - FACS and Cell Sorting -
Beckman Coulter Cytoflex LX (5 lasers, 21 channels)
Cytek Northern Lights (3 laser, full spectrum)
Contact: Chris Pepper (C.Pepper@bsms.ac.uk)
Professor of Cancer Research
Sequencing
What does this do? Investigate the role of genes in cancer diagnosis, prognosis and treatment.What is available and how do I access it? -
NextSeq1000
DRAGEN informatics
Contact: Matt Neale (M.Neale@sussex.ac.uk)
-
Nanopore PromethION 2 Solo
10x Genomics Controller (scRNAseq)
Contact:
Sarah Newbury (S.Newbury@bsms.ac.uk)Simon Mitchell (S.A.Mitchell@bsms.ac.uk)
Ben Towler (B.Towler2@bsms.ac.uk)
-
NextSeq500
Contact: Rameen Shakur (knowledgeexchange@brighton.ac.uk)
Drug Discovery and Development
What does this do? Turns drug targets into molecules that can be used in clinical trials.What is available and how do I access it? 
-
We have the capability, expertise and experience to prosecute drug targets across a variety of therapeutic areas.
Our core focus is set within the areas of medicinal chemistry, protein structural biology, cancer biology, ion channel physiology and pharmacology, and endothelial biology.
Contact: Professor Erika Mancini (Erika.Mancini@sussex.ac.uk) – SDDC director
Professor John Spencer (J.Spencer@sussex.ac.uk ) - Head of Medicinal Chemistry
Clinical Trials
What does this do? Clinical trials are the final stepping stone before helping patients with new therapiesWhat is available and how do I access it? -
Development of funding applications
Trial design
Study management
Quality assurance
Data analysis
Dissemination
Trial close-down
Contact: Dr Wendy Wood (W.Wood@bsms.ac.uk)
CTU Director
Patient Material
What does this do? Invaluable resource for scientists to discover new drug targets, and develop new treatment approaches.
What is available and how do I access it? -
Urological Cancers: Prostate, kidney, bladder and testicular cancer.
Contact:
Andy Symes (andrew.symes@nhs.net)
Consultant Urologist -
Duncan Gilbert (duncan.gilbert2@nhs.net)
Isobelle coombes (isobellecoombes@nhs.net)
Rebecca Herbertson (rebecca.herbertson@nhs.net)
… and many more. Contact hello@sussexcancer.org describing what you are looking for.
-
John Jones (J.Jones2@bsms.ac.uk)
Can’t find what you’re looking for?
… and we’ll put you in touch with the right person!